Status:
RECRUITING
Cognitive Function After Radiation Therapy for Primary Brain Tumours
Lead Sponsor:
University of Aarhus
Conditions:
Primary Brain Tumour
Radiation Toxicity
Eligibility:
All Genders
18-100 years
Brief Summary
This study will assess cognitive function in patients with a primary brain tumour treated with radiation therapy (RT) to generate radio-sensitivity and volume effect parameters for the development of ...
Detailed Description
RT is fundamental in the treatment of primary brain tumours. RT contributes to improved local control and prolonged progression-free survival in patients with a broad range of tumour types. Irradiatio...
Eligibility Criteria
Inclusion
- 18 years or older and Danish speaking.
- Performance status WHO 0-2
- Capable of cooperating on testing
- Tumour histology (WHO 2016 classification) of the following types: anaplastic astrocytoma (IDH mutant), diffuse astrocytoma (IDH-mutant), gemistocytic astrocytoma (IDH mutant), diffuse astrocytoma (NOS), oligodendroglioma, meningioma, medulloblastoma (NOS), pituitary adenoma, other brain tumours including skull base sarcomas
Exclusion
- Glioblastoma
- Performance status 3-4 (Karnofsky Performances of 60 or less)
Key Trial Info
Start Date :
January 3 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 31 2034
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04306432
Start Date
January 3 2019
End Date
March 31 2034
Last Update
December 2 2021
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Oncology, Rigshospitalet
Copenhagen, Capital Region, Denmark, 2100
2
Danish Center for Particel Therapy
Aarhus, Region Midt, Denmark, 8200
3
Department of Oncology, Aarhus University Hospital
Aarhus, Region Midt, Denmark, 8200
4
Department of Oncology, Aalborg University Hospital
Aalborg, Region Nord, Denmark, 9000